Company / Depreciation & Amortization
Nutex Health, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$20.5M
FY2025
5-year range
$7.7M / $20.5M
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#259 of 294
Industrials
What the data says
Nutex Health, Inc.'s depreciation & amortization of $21M is lower than 88% of companies in the Industrials sector (FY2025). Depreciation & Amortization has increased for 8 consecutive years, from $473 in FY2016 to $21M in FY2025.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +28.3%.
Increased from $18M to $21M over the past 2 years.
Industrials sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +16.1%
- 5-Year CAGR
- +28.3%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in IndustrialsTop 12% of 294This company $20.5M Sector average $312.6M
▼
-93.4% below sector average
Key checks
Key Insights
- Nutex Health, Inc.'s depreciation & amortization has grown for 7 consecutive years.
- 5-year CAGR of +28.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 8.2% year-over-year.
- Ranks #259 out of 294 companies in the Industrials sector.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.5M | +8.2% |
| FY2024 | $19.0M | +7.8% |
| FY2023 | $17.6M | +34.0% |
| FY2022 | $13.1M | +71.4% |
| FY2021 | $7.7M | +29.9% |
| FY2020 | $5.9M | +3678.8% |
| FY2019 | $156.1K | +5713.5% |
| FY2018 | $2.7K | - |
| FY2017 | - | - |
| FY2016 | $473 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026